Connect with us

Politics

This Is The Most Marijuana-Friendly Congress In History

Published

on

With the House and Senate heading into a month-long August recess this week, it’s a good time to look back at what lawmakers have accomplished so far this year when it comes to marijuana reform: It is unquestionable that the 116th Congress is the most cannabis-friendly Congress in history.

Seven months into the session, there have already been seven hearings on cannabis, a marijuana banking bill passed a key committee and the full House adopted a far-reaching amendment to block federal interference in state legalization laws. And those are just the highlights.

“Congress has never moved this far, this fast on marijuana policy, period,” NORML Political Director Justin Strekal said in an interview.

Rep. Earl Blumenauer (D-OR), who has worked for decades to end marijuana prohibition, said that those “long overdue efforts to reform our outdated cannabis laws are finally resonating in Congress.”

“Bills to address policy failures in cannabis banking, veterans access, decriminalization and restorative justice have started moving through the legislative process,” he said.

Here’s a comprehensive rundown of the immense amount of cannabis progress made on Capitol Hill in 2019:

Votes On Marijuana Legislation

In June, the House of Representatives voted 267 to 165 to approve a measure for the first time that prevents the Department of Justice from spending money to intervene in the implementation of state and territory marijuana policies.

The body also approved, via an uncontested voice vote, a similar measure shielding the cannabis laws of Indian tribes as well as another adding the U.S. Virgin Islands to an existing law covering local medical marijuana programs. An additional amendment the House tacked onto the same bill directs the Food and Drug Administration to establish a process for regulating CBD in foods and dietary supplements.

Separate appropriations legislation that cleared the House in June contained language upon introduction to prohibit the Treasury Department from punishing banks for maintaining accounts for state-legal cannabis businesses. That legislation also deletes a longstanding rider that has blocked Washington, D.C. from spending its own local tax dollars to legalize and regulate marijuana sales. No lawmaker from either party attempted to completely strip the banking language or add the D.C. ban back in.

The Senate has not yet taken up its versions of these spending bills, so it remains to be seen if the chamber will support similar amendments during committee markups or floor consideration. In cases where the body does not adopt identical proposals, it will be up to bicameral conference committees to determine what makes it into final legislation sent to President Trump’s desk.

In July, the House passed via voice vote an amendment to end a Department of Veterans Affairs policy that denies home loans to military veterans because they work in the marijuana industry. The underlying bill, the National Defense Authorization Act (NDAA), also contains a separate measure added in committee that would let military branches grant reenlistment waivers to personnel if they used marijuana once, or were convicted of a misdemeanor cannabis offense, while off duty. The Senate version of NDAA doesn’t have these marijuana riders, so it will come down to a conference committee to decide if they are included in the finished package.

In March, the House Financial Services Committee voted 45 to 15 to approve a bill to let banks service marijuana businesses without being punished by federal regulators.

Much of the progress on cannabis legislation so far this year is due to the fact that Democrats won control of the House and thereby replaced former Rules Committee Chairman Pete Sessions (R-TX)—who lost his own reelection bid—with new Chairman James McGovern (D-MA). The panel is responsible for preparing legislation for floor action and, among other things, decides which amendments are allowed to be voted on by the full body. Under Sessions’s control, the GOP majority blocked every proposed cannabis measure from advancing for the past several years. McGovern has allowed nearly all marijuana amendments to be considered on the floor, with the exception of one that had technical issues in violation of House rules.

It is worth noting that it hasn’t been all legislative victories for drug reform activists this year on Capitol Hill. A measure that Rep. Alexandria Ocasio-Cortez (D-NY) filed to remove roadblocks to research on the medical benefits of psilocybin, MDMA and other psychedelics was soundly defeated on the House floor, with a number of Democratic leaders joining the GOP in voting against it. And Blumenauer withdrew his own amendment to let Department of Veterans Affairs doctors issue medical cannabis recommendations after the administration pushed back against it. Planned committee votes on other veterans-focused marijuana legislation were canceled and haven’t yet been rescheduled.

And while supporters had anticipated a House floor vote on the cannabis banking bill prior to the August recess, that did not happen, and expectations have now shifted toward action in the fall.

Hearings On Cannabis Issues

An unprecedented number of hearings have already been held on Capitol Hill this year to zero in on specific issues caused by the growing gap between federal and state cannabis laws.

The Senate Banking, Housing and Urban Affairs Committee held a hearing on financial services access for marijuana businesses on July 23—a surprise to advocates following the earlier refusal of Chairman Mike Crapo (R-ID) to commit to considering the issue while cannabis remains federally banned. While the event was poorly attended by panel Republicans, it at least signals the GOP-controlled body’s willingness to discuss key reforms. It is unknown if or when the committee will vote on pending marijuana banking legislation that is currently cosponsored by nearly a third of all senators.

The Senate Agriculture Committee convened a July 25 hearing on federal officials’ efforts to implement the legalization of hemp that was part of the 2018 Farm Bill signed into law by President Trump late last year. Among those who testified were representatives from the U.S. Department of Agriculture, the Food and Drug Administration and the Environmental Protection Agency.

On the House side, the Judiciary Subcommittee on Crime, Terrorism and Homeland Security gathered on July 10 for a hearing on the need to end cannabis prohibition at which every witness—including the one called by the panel’s minority Republicans—supported far-reaching federal marijuana reform. Lawmakers from both parties also broadly voiced support for ending or scaling back prohibition, with most disagreement centering on how to achieve change instead of whether changes are needed.

The House Veterans’ Affairs Committee held two hearings this year at which legislators discussed proposals to increase military veterans’ access to medical cannabis. During a full panel session in June as well as a separate earlier meeting of the Subcommittee on Health, a key focus was on bipartisan proposals to force the Department of Veterans Affairs to at least study medical marijuana.

Also in June, the House Small Business Committee discussed challenges facing firms in the cannabis industry, including a lack of access to federally backed low-interest loans.

In February, the House Financial Services Consumer Protection and Financial Institutions Subcommittee convened to discuss banking access issues for marijuana businesses, a hearing that preceded full committee passage of legislation on the issue.

Marijuana Bills From Key Sponsors

No fewer than 61 individual cannabis-focused bills have been filed in the first seven months of the 116th Congress, and that doesn’t count a number of broader large-scale bills that happen to contain cannabis provisions. Beyond the sheer volume of legislation—already nearly the most in any single two-year Congress despite the fact that barely a quarter of the current one has so far elapsed—the names of the lead sponsors signal how seriously cannabis reform is now being taken on Capitol Hill

From committee chairs to presidential candidates, many of the most serious players in the House and Senate are stepping up to play leadership roles in the fight to reform federal marijuana laws.

Rep. Jerrold Nadler (D-NY), who strongly influences crime and drug policy as House Judiciary Committee chair, and Sen. Kamala Harris (D-CA), a presidential contender, teamed up to file companion bills that would not only federally legalize marijuana but invest in programs aimed at repairing some of the damage of the war on drugs.

House Small Business Committee Chair Nydia Velazquez (D-NY) introduced legislation to let marijuana firms utilize loans and other programs from the Small Business Administration and to increase the cannabis industry’s access to insurance coverage.

Senate Minority Leader Chuck Schumer (D-NY) and House Democratic Caucus Chairman Rep. Hakeem Jeffries (D-NY) filed bills to deschedule cannabis and set aside funding to support expunging prior convictions.

Every Democratic senator and representative currently running for their party’s 2020 presidential nomination has signed onto far-reaching cannabis legislation, with some taking extra initiative as the lead sponsors of bills.

Sen. Cory Booker (D-NJ), for example, filed a proposal called the Marijuana Justice Act, which would remove cannabis from the Controlled Substances Act (CSA) and punish states with discriminatory prohibition enforcement by withholding certain federal funds. Sen. Elizabeth Warren (D-MA) is a lead sponsor of bipartisan legislation to exempt state-legal marijuana activity from the CSA. Rep. Tulsi Gabbard (D-HI) filed bills to deschedule marijuana and to research hemp’s potential uses for everything from products for public school lunches to clearing contaminants from nuclear sites.

Sens. Michael Bennet (D-CO), Kirsten Gillibrand (D-NY), Amy Klobuchar (D-MI) and Bernie Sanders (I-VT), as well as Reps. Seth Moulton (D-MA) and Tim Ryan (D-OH)—all also presidential candidates—have signed onto cannabis reform proposals.

While Democrats have been much more likely to introduce or cosponsor marijuana reform bills so far this Congress, some measures have garnered significant bipartisan support.

Legislation to let banks serve cannabis businesses without fear of being punished by federal regulators, for example, has 206 House cosponsors—nearly half the chamber’s entire membership—including 26 Republicans. A companion Senate bill has 31 lawmakers signed on, including five GOP senators. And Warren’s bill, known as the STATES Act, also has five Republican cosponsors, with the companion House version touting 19 GOP signers.

Report Language On Cannabis

Beyond advancing legislation containing marijuana reform provisions, the House Appropriations Committee has included language directing federal agencies to take action on cannabis issues in several reports attached to spending bills this year.

In a document corresponding to legislation to fund the Departments of Labor, Health and Human Services and Education, the panel expressed concern that cannabis’s current federal classification impedes science, writing that “restrictions associated with Schedule I of the Controlled Substance Act effectively limit the amount and type of research that can be conducted on certain Schedule I drugs, especially marijuana or its component chemicals and new synthetic drugs and analogs.”

“At a time when we need as much information as possible about these drugs to find antidotes for their harmful effects, we should be lowering regulatory and other barriers to conducting this research,” the panel said, directing the National Institute on Drug Abuse to “provide a short report on the barriers to research that result from the classification of drugs and compounds as Schedule I substances.”

A separate report for legislation funding the Department of Justice urges the Drug Enforcement Administration to “expeditiously process any pending applications for authorization to produce marijuana exclusively for use in medical research,” expressing frustration that the federal government has so far not acted on more than two dozen pending proposals to grow cannabis for scientific studies.

A document attached to the Financial Services and General Government spending bill encourages the Office of Personnel Management to “review its policies and guidelines regarding hiring and firing of individuals who use marijuana in states where that individual’s private use of marijuana is not prohibited under the law of the State.”

“These policies should reflect updated changes to the law on marijuana usage and clearly state the impact of marijuana usage on Federal employment,” the report says.

Legislation on Agriculture, Rural Development and Food and Drug Administration funding has an attached report urging federal officials to issue hemp legalization regulations “as soon as possible” and identify “lawful federal regulatory pathways for CBD foods and dietary supplements if such pathways are consistent with protection of the public health.”

The committee also included a passage in the report attached to a bill funding the Department of Veterans Affairs decrying the “Department’s denial of home loan guarantees to Veterans solely on the basis of the Veteran’s documented income being derived from state-legalized cannabis activities” and directing it to provide an update on efforts to “prioritize investments in research on the efficacy and safety of cannabis usage among the Veteran population for medicinal purposes.”

Looking Ahead

There’s still nearly a year and a half left to go in the 116th Congress, and legalization advocates are hopeful that far-reaching reforms can pass one or both chambers, potentially making it to President Trump’s desk to be signed into law.

Michael Collins, director of national affairs for the Drug Policy Alliance, said that things are “off to a great start in the House,” calling the Judiciary Committee hearing and the introduction of its chairman’s bill “highlights” so far.

“But there is so much more to be done before we can celebrate undoing the horror that is marijuana prohibition,” he added.

Most immediately, activists will be watching to see if the House moves to pass cannabis banking legislation and potentially Judiciary Chair Nadler’s comprehensive marijuana reform bill when Congress returns from the August recess this fall.

Blumenauer, the pro-legalization congressman, said that he hopes the body will consider Nadler’s descheduling legislation “before the end of the year.”

“This is our blueprint in action, and I expect our momentum to continue,” he said, referring to a memo he issued to Democratic leaders last year laying out a committee-by-committee process through which the the party could build support toward ending cannabis prohibition in 2019.

On the other side of the Capitol, it remains to be seen whether the Senate Banking Committee will take up that chamber’s version of the cannabis financial services proposal following the hearing the panel held in July, or whether broader reforms such as the STATES Act or other marijuana legislation will be allowed to advance under Majority Leader Mitch McConnell (R-KY).

While bill introductions, hearings and report language are undoubtedly positive steps forward—especially in a quantity never before seen on Capitol Hill—they in and of themselves don’t change any laws, get anyone out of jail or repair the harms of the drug war.

Strekal, of NORML, said that “lawmakers are increasingly playing catch up with their constituents.”

“It’s our job as advocates to ensure that, as these elected officials evolve, they navigate their positions towards sound public policy, not simple political expediency,” he said.

But even if no other marijuana action were to happen on Capitol Hill this or next year—as unlikely as that would be—it is clear that the 116th Congress has already been the most marijuana friendly in history.

This piece was first published by Forbes.

Image element courtesy of Tim Evanson.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Tom Angell is the editor of Marijuana Moment. A 20-year veteran in the cannabis law reform movement, he covers the policy and politics of marijuana. Separately, he founded the nonprofit Marijuana Majority. Previously he reported for Marijuana.com and MassRoots, and handled media relations and campaigns for Law Enforcement Against Prohibition and Students for Sensible Drug Policy. (Organization citations are for identification only and do not constitute an endorsement or partnership.)

Politics

Mexican Lawmakers Circulate Amended Marijuana Legalization Bill That’s Set For A Vote On Monday

Published

on

Lawmakers in Mexico’s Chamber of Deputies are finally set to take up a bill to legalize marijuana nationally in the coming days, but the proposal has recently been subject to several significant revisions since being approved by the Senate last year.

First, a joint hearing of the chamber’s Health and Justice committees will take place on Monday, and a vote in the full chamber is expected the following day or on Wednesday. Advocates have been eagerly awaiting the introduction of new language, hopeful that it would address certain concerns with the Senate proposal, and now they’re getting details about what is being changed by the joint panels.

Generally speaking, most of the main provisions of the legislation remain intact. Adults 18 and older would still be allowed to purchase and possess up to 28 grams of marijuana and cultivate up to six plants for personal use, for example. But lawmakers revised the regulatory structure, rules for the commercial market and licensing policies, among other aspects.

Among the most significant amendments is that the revised bill would not establish a new independent regulatory body to oversee the licensing and implementation of the program as was approved by the Senate. Instead, it would give that authority to an existing agency, the National Commission Against Addictions.

Another change would be the creation of a license category for vertically integrated marijuana businesses that could control all areas of production and sales. However, there is language included in the measure to “prevent undue concentration that affects the market.”

While the bill would give priority for those licenses to marginalized communities, advocates are worried that there might not be strict criteria to actually ensure that ends up being the case. They had wanted to specific percentage of licenses to be set aside for those communities, but that’s not in the new bill.

For the purposes of public consumption, cannabis would be treated the same as tobacco under the amended legislation, but it could not be sold online or through the mail.

According to Heraldo de Mexico, the amended legislation includes “substantive modifications” to 15 provisions, deletes seven components and adds five new ones.

The text of the revised measure also seeks to reframe the reform as being about protecting public health rather than economic growth.

“Given that the proposed legislation would open the legal market for cannabis, a substance considered to be a narcotic in the international treaties signed by our country, it is essential that the law issued for this purpose has a clear and defined public health approach,” it says. “For this reason, it is essential to modify the approach that predominates in the bill, which considers the cultivation of cannabis as a means for economic growth and community development; which, if maintained like this, would encourage production and commercialism, neglecting public health, contrary to the guiding model that these committees intend to build.”

Already, there’s been criticism of the revised bill.

The advocacy group Mexico Unido said that the revised proposal still “criminalizes users, puts criminal and administrative sanctions on them and invades their privacy.”

“The current ruling removed the locks on vertical market integration and the entry of the junk food and beverage industry,” it said. “And it did not eliminate excessive requirements such as seed control, traceability and testing, which exclude small participants.”

Activists are happy, however, that a proposed permitting requirement for people to grow their own cannabis that was included in an earlier draft in circulation is no longer in the new version. They also appreciate that proposed fines for possessing too much marijuana have been reduced.

“The Federal Law for the Regulation of Cannabis is intended, through a public health approach, to link the right to consume cannabis with the right to production for self-consumption, either personally in homes, or as participants in legally constituted civil associations,” the bill states. “Through the proposed system, the production of cannabis and its derivatives would be aimed at self-consumption, either at home or in cannabis associations.”

There would be six licensing categories under the proposal: production, distribution, sales, marketing and research—in addition to one that would provide for vertical integration.

Another change in the latest version concerns edibles, which would not be allowed to be marketed on a temporary basis until additional research is conducted into the products, 24 Horas reported.

Martha Tagle Martínez, a member of the chamber’s Health Committee, said earlier this week that the original Senate reform legislation did not fulfill the requirements of the Supreme Court, which deemed the prohibition on personal possession and cultivation of marijuana unconstitutional in a 2018 ruling. Lawmakers have since been tasked with ending criminalization, but they’ve repeatedly pushed back deadlines to enact the policy change.

Now the legislature has until the end of April to legalize cannabis nationwide, and it seems next week’s action will set the stage for Congress to make good on its obligation.

In the meantime, the Health Committee already held a preliminary discussion on the issue last month.

Members of the panel said they wanted to hold four sessions to debate the legislation, but its president, Carmen Medel Palma, has yet to convene them and wants to speed up the process, La Jornada reported.

The Justice Committee also met to discuss the matter on Sunday, according to the group Cáñamo México. The two panels were initially expected to send a revised legalization proposal to the floor last month, but that didn’t happen. However, they met jointly on Thursday to discuss the latest version in advance of the expected formal approval on Monday.

MartĂ­nez of the Health Committee has signaled that she doesn’t feel lawmakers have been provided sufficient time to analyze the revised bill ahead of the planned floor vote in the coming days.

President Andres Manuel Lopez Obrador, for his part, said in December that an earlier anticipated vote on legalization legislation was delayed due to minor “mistakes” in the proposal.

He said “there was no time to conduct a review” in the legislature before the prior December 15 Supreme Court deadline, but he noted that issues that need to be resolved are “matters of form” and “not of substance.”

The Senate passed the legalization bill in November and transmitted it to the Chamber of Deputies. Several committees took up the bill, with the Human Rights and Budget and Public Account Committees representing one panel that considered and advanced it just before the the court granted lawmakers’ latest deadline extension request.

While advocates are pushing for lawmakers to formally end prohibition, they hoped the delay would give them more time to try to convince the legislature to address their concerns about certain provisions of the current bill, namely the limited nature of its social equity components and strict penalties for violating rules.

The legalization bill cleared a joint group of Senate committees prior to the full floor vote in that chamber, with some amendments being made after members informally considered and debated the proposal during a virtual hearing.

Members of the Senate’s Justice, Health, and Legislative Studies Committees had approved a prior version of legal cannabis legislation last March, but the coronavirus pandemic delayed consideration of the issue.

The legislation as ultimately approved by the Senate made some attempts to mitigate the influence of large marijuana corporations. For example, it stated that for the first five years after implementation, at least 40 percent of cannabis business licenses must be granted to those from indigenous, low-income or historically marginalized communities.

Households where more than one adult lives would be limited to cultivating a maximum of eight plants. The legislation also says people “should not” consume cannabis in homes where there are underaged individuals. Possession of more than 28 grams but fewer than 200 grams would be considered an infraction punishable by a fine but no jail time.

Sen. Julio Ramón Menchaca Salazar of the MORENA party said in April that legalizing cannabis could fill treasury coffers at a time when the economy is recovering from the pandemic.

As lawmakers work to advance the reform legislation, there’s been a more lighthearted push to focus attention on the issue by certain members and activists. That push has mostly involved planting and gifting marijuana.

In September, a top administration official was gifted a cannabis plant by senator on the Senate floor, and she said she’d be making it a part of her personal garden.

A different lawmaker gave the same official, Interior Ministry Secretary Olga Sánchez Cordero, a marijuana joint on the floor of the Chamber of Deputies in 2019.

Cannabis made another appearance in the legislature in August, when Sen. Jesusa Rodríguez of the MORENA party decorated her desk with a marijuana plant.

Drug policy reform advocates have also been cultivating hundreds of marijuana plants in front of the Senate, putting pressure on legislators to make good on their pledge to advance legalization.

Read the text of the revised Mexico legalization bill below: 

Mexican Chamber of Deputies… by Marijuana Moment

West Virginia Governor Would Support Taxing The ‘Absolute Crap’ Out Of Marijuana To Replace Income Tax

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

West Virginia Governor Would Support Taxing The ‘Absolute Crap’ Out Of Marijuana To Replace Income Tax

Published

on

The governor of West Virginia isn’t personally a fan of marijuana legalization, but for the second time in a week, he said that he’d support the reform if the legislature sent a bill to his desk.

In response to a question about the prospect of taxing “the absolute crap” out of cannabis, Gov. Jim Justice (R) said during a virtual town hall event on Friday that he’s “not a proponent of recreational marijuana.” However, he noted, “it seems like the entire nation is going to end up moving that way.”

“If in fact the entire nation is going to move that way, if our legislature from the standpoint of the Republicans in the House were to bring me that, and it would be tied to using those extra dollars [to] get rid of additional personal income tax, I would support it,” he said.

Watch Justice talk about marijuana reform policy in the video below: 

“I’m not in favor, but I would support it if people got on board and brought that to me,” the governor said.

The voter who posed the question was primarily concerned that no new taxes be placed on nicotine vaping products, and wanted to suggest legalizing cannabis as an alternative means to raise revenue.

“Please don’t do a 70 dollar tax on my vapes, man,” he told the governor.

Friday’s event was focused on the state’s move to eliminate the personal income tax, but this isn’t the first time that Justice discussed how regulating cannabis sales could factor into that effort.

On Tuesday, he similarly said that he’d be inclined to sign legalization legislation if lawmakers sent it to him, in part because he’s heard from he’s from members of the medical community who feel that regulating cannabis sales could actually reduce “drug-type problems” like the opioid overdose epidemic, which has hit his state especially hard.

“I’ll just tell it like it is, I’m not educated enough to make a really good assessment as of yet,” he said. “But I can tell you just this: I do believe that that is coming, and the wave is coming across all of our states, and as that wave comes, if our House Republicans and Democrats and Senate Republicans and Democrats would get behind that effort from a standpoint of legalization of recreational marijuana and they would be supportive of that, I would too.”

These comments come after House Majority Whip Paul Espinosa (R) circulated an internal poll among Republican lawmakers, inquiring about what kind of policies—including marijuana legalization—they’d be willing to support to make up revenue for the state as part of the plan to gut the income tax.

When asked about legalization as a means to raise tax revenue that could theoretically be used to get ride of the income tax, the governor said this week that he’s principally opposed to broad reform but “I’m weakening on that position” because while his instinct is to reject regulating marijuana amid the state’s drug crisis, the medical community has shifted his perspective.

Experts “tell me that really and truly the legalizing of marijuana in certain areas or certain states that have that, from a recreational standpoint, have lowered their drug-type problems,” he said.

“If we could bucket the proceeds [from cannabis tax revenue] and use them in a way, just like this personal income tax reduction…in a really beneficial way for all our people,” he would be supportive of that.

West Virginia approved medical cannabis legalization in 2017, which Justice signed into law, and patients were just recently approved to start registering for the program. That said, the state must still partner with a testing laboratory before marijuana products are made available.

Two Democratic candidates who lost their bids for West Virginia House seats last year had pledged to introduce legislation to legalize marijuana in the state if they were elected.

Local Activists In Washington State Push For Psilocybin Decriminalization

Photo courtesy of WeedPornDaily.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Local Activists In Washington State Push For Psilocybin Decriminalization

Published

on

Voters in Spokane, Washington could make the city one of the latest to decriminalize psilocybin mushrooms under a proposed ordinance that was recently filed by local activists.

The initiative, which was introduced by the group Decriminalize Spokane, would make enforcement of laws prohibiting the personal possession, cultivation and limited distribution of psilocybin for adults 21 and over among the city’s lowest priorities and would further ban officials from using “any city funds or resources to assist in the enforcement of laws imposing criminal penalties for the use, possession, transportation, cultivation, or distribution of psilocybin mushrooms.”

The measure, which activists intend to qualify for the city’s ballot, includes stipulations prohibiting the use or display of the psychedelic fungi in public spaces.

The “whereas” section of the measure points to scientific research on the therapeutic potential of psilocybin and the relatively low health risks it poses.

“Psilocybin can alleviate end-of-life anxiety for hospice and terminal cancer patients, can reduce prison recidivism, and can effectively treat depression, cluster headaches, addiction and trauma,” it says.

The proposed ordinance was submitted to the City Council last month, and lawmakers had the option of endorsing and enacting it into law themselves, rejecting it and proposing an alternative or approving the petition and placing it before voters. But while the proposal was on the agenda for Monday, local legislators chose not to act, which means it will be vetted by city officials to ensure its language is lawful and then cleared for signature gathering by activists.

If they are successful in collecting enough valid petitions from registered voters, the ordinance could go before voters as early as November of this year. As currently drafted, here’s the language of the ballot question that voters would see:

“Shall the Spokane Municipal Code be amended to make adult possession and transfer of limited quantities of psilocybin mushrooms the lowest possible law enforcement priority?”

According to The Spokane Spokesman-Review, activists will need 3,477 signatures to put the reform on the ballot.

Mason Lord, the chief petitioner, told the local newspaper that the proposal “is mostly about safety, and this is acknowledging certain legal substances that are accessible—like alcohol, for one—are far more dangerous.” He added that it’s about “the criminalization of a substance that has so much research showing that it’s so much safer than legal substance adults (can access).”

This is the latest iteration of a the decriminalization movement that’s evolved since Denver became the first city in the U.S. to decriminalize psilocybin mushrooms in 2019 via a citizen initiative.

Six other cities—Oakland, Santa Cruz, Ann Arbor, Washington, D.C., Somerville and Cambridge—have decriminalized possession of a broader collection plant-and fungi-based psychedelics since Denver’s move.

In Oregon, voters approved historic initiatives to legalize psilocybin for therapeutic purposes and decriminalize drugs more broadly in November.

Legislators in California, Connecticut, Florida, Hawaii, Kansas, Missouri, Washington State and Virginia are also considering psychedelics and drug policy reform bills for the 2021 session.

A Republican lawmaker in Iowa introduced a bill to remove psilocybin from the list of controlled substances, which received a subcommittee hearing this week but did not advance. He also filed another piece of legislation to let seriously ill patients use psychedelic mushrooms, LSD, DMT and other drugs.

Read the text of the Spokane psilocybin decriminalization ordinance below: 

Spokane Psilocybin Decrimin… by Marijuana Moment

Hawaii Governor Has ‘Concerns’ About Legalization Bill Advancing In Legislature

Photo courtesy of Dick Culbert.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Marijuana Moment